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Hypoplastic Left Heart Syndrome Is Heritable
Robert B. Hinton, JR, MD,* Lisa J. Martin, PHD,† Meredith E. Tabangin, MPH,†
Mjaye L. Mazwi, MD,* Linda H. Cripe, MD,* D. Woodrow Benson, MD, PHD*
Cincinnati, Ohio
Objectives This study sought to determine the size of the genetic effect (heritability) in families identified by a hypoplastic
left heart syndrome (HLHS) proband.
Background Hypoplastic left heart syndrome is a severe form of cardiovascular malformation (CVM), and it remains a leading
cause of infant mortality and childhood morbidity. Familial clustering of HLHS and bicuspid aortic valve (BAV)
has been observed, and pedigree analysis has suggested recessive inheritance. The genetic significance of these
observations is unknown.
Methods In 38 probands with HLHS, a 3-generation family history was obtained; using a sequential sampling strategy,
echocardiograms on family members were performed. A total of 235 participants were recruited. Heritability
(h2) of HLHS and associated CVM was estimated using maximum-likelihood-based variance decomposition.
Results All HLHS probands had aortic valve hypoplasia and dysplasia; dysplasia of the mitral (94%), tricuspid (56%), and pul-
monary (11%) valves was also noted. Overall, 21 of 38 (55%) families had more than 1 affected individual, and 36%
of participants had CVM, including 11% with BAV. The heritability of HLHS alone and with associated CVM were 99%
and 74% (p  0.00001), respectively. The sibling recurrence risk for HLHS was 8%, and for CVM was 22%.
Conclusions The high heritability of HLHS suggests that it is determined largely by genetic factors. The frequent occurrence of
left- and right-sided valve dysplasia in HLHS probands and the increased prevalence of BAV in family members
suggests that HLHS is a severe form of valve malformation. (J Am Coll Cardiol 2007;50:1590–5) © 2007 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.07.021H
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pypoplastic left heart syndrome (HLHS) (MIM#241550)
emains a leading cause of infant death due to cardiovascular
alformation (CVM) and is associated with significant
ong-term morbidity. Despite remarkable advances in diag-
osis and therapy, little is known of the etiology of HLHS
1,2). Several observations suggest a genetic basis. Based on
See page 1596
edigree analysis of multiplex families in a consanguineous
opulation, autosomal recessive inheritance has been pro-
osed (3). The idea that left-sided lesions, namely bicuspid
ortic valve (BAV) (MIM109730), aortic coarctation, and
LHS, are causally related was based on epidemiology
tudies that identified BAV in first-degree relatives of
rom the Divisions of *Cardiology and †Biostatistics and Epidemiology, Cincinnati
hildren’s Hospital Medical Center, Cincinnati, Ohio. Supported by a Trustee
ward from Children’s Hospital Research Foundation (to Dr. Hinton), Cincinnati,
hio, and grants from the National Institutes of Health HD43005 (to Dr. Hinton),
L085122 (to Dr. Hinton), MH059490 (for Sequential Oliogogenic Linkage
nalysis Routines software package, San Antonio, Texas), HL069712 (to Dr.
enson), and HL074728 (to Drs. Martin, Cripe, and Benson), Bethesda, Maryland.f
Manuscript received April 4, 2007; revised manuscript received June 28, 2007,
ccepted July 1, 2007.LHS probands (4,5). Bicuspid aortic valve frequently
nderlies aortic stenosis in patients of all ages, and longitu-
inal studies in the fetus have identified HLHS as part of
he in utero natural history of aortic stenosis, suggesting that
hese defects may share a common etiology (6,7). Several
tudies have noted an increased prevalence of CVM in
amilies identified by an HLHS proband (4,5,8). Familial
lustering of BAV has been documented (5,9,10), and both
AV and left-sided lesions taken together have been shown
o be heritable (11,12). However, the size of the genetic
ffect of HLHS remains unknown.
Classification of HLHS, based on the pathologic anat-
my of the aortic and mitral valves, has been widely
ccepted (13–15). In this scheme, HLHS is defined as
tresia or stenosis of the aortic and mitral valves and
ypoplasia of the left ventricle and ascending aorta. Hypo-
lastic left heart syndrome pathology series have shown that
ortic valve malformation is universal and mitral valve
bnormalities are common (16,17); however, despite a
onventional emphasis on left-sided heart structures, both
ricuspid and pulmonary valve dysplasia have been reported
16,18,19). It is unclear to what extent aortic valve mor-
hology and right-sided valve involvement can be used to
urther refine the HLHS phenotype.
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October 16, 2007:1590–5 HLHS Is HeritableIn this study, we estimated heritability to determine the
ize of the genetic effect of HLHS. We found that HLHS
s determined largely by genetic factors. In addition, we
dentified a high incidence of left-sided and right-sided
alve dysplasia in probands and an increased prevalence of
AV in family members.
ethods
roband recruitment and sequential sampling. Probands
ith HLHS were recruited from the Division of Cardiology
t Cincinnati Children’s Hospital Medical Center. Family
embers were recruited using a sequential sampling strategy
11). Briefly, each proband’s first-degree relatives were
valuated, and for every new affected individual identified,
ll of that individual’s first-degree relatives were evaluated.
hen the family history identified affected second-degree
elatives, sampling was extended to include the first-degree
elatives. Informed consent was obtained from each partic-
pant or participant’s parent or guardian. Assent was ob-
ained from pediatric participants when appropriate. This
tudy was approved by the Institutional Review Board at
incinnati Children’s Hospital Medical Center.
roband inclusion and exclusion criteria. Hypoplastic
eft heart syndrome was strictly defined as atresia or stenosis
f the aortic and mitral valves and hypoplasia of the left
entricle and ascending aorta with intact ventricular septum
15). Patients with complex CVM and left ventricular
ypoplasia (e.g., variants of unbalanced atrioventricular
eptal defects, double-outlet right ventricle, or Shone anom-
ly) were excluded. Patients with known genetic syndromes
e.g., trisomy 18 or Turner syndrome) also were excluded.
chocardiographic analysis. Cross-sectional 2-dimensional
nd Doppler transthoracic echocardiography was performed
n all participants using Hewlett-Packard Sonos 5500
Philips, Eindhoven, the Netherlands), Vivid 5 or Vivid 7
ystems (General Electric, Fairfield, Connecticut). A de-
ailed echocardiographic protocol previously described was
sed to assess cardiovascular structures (11). A single expe-
ienced echocardiographer (L.H.C.) interpreted all echocar-
iograms. To assess valve anatomy in HLHS probands,
chocardiographic studies performed in the newborn period
efore surgical intervention were reviewed. Valve hypoplasia
as defined as an annulus dimension z score 2. Valve
ysplasia was defined as cusp or leaflet thickening, redun-
ancy, or immobility. Bicuspid aortic valve was defined as a
icommissural appearance in the parasternal short-axis
chocardiographic view and was classified as right-left or
nterior-posterior (11,20,21). Unicuspid aortic valve mor-
hology was classified as unicommissural or acommissural
ased on appearance in the parasternal short-axis view
20,22).
tatistical analysis: heritability of HLHS. To determine
he extent to which genes influence the development of
LHS, we used variance component methodology im-lemented in the computer package Sequential Oligo- 1enic Linkage Analysis Routines
SOLAR, San Antonio, Texas).
he phenotypic variance (2P)
s derived from the additive ge-
etic (2G) and residual or epi-
enetic (2E) effects. The herita-
ility (h2) or overall genetic effect
s estimated as h2  2G/
2
P.
his nonparametric approach does
ot require a model of inheritance
nd allows analysis of all relative
airs (23).
The recruitment strategy re-
ulted in a population enriched
or HLHS and associated CVM. Ascertainment is neces-
ary to identify sufficient numbers of affected individuals
hen studying a rare disease. Accordingly, the appropriate
opulation prevalence is constrained to correct for ascertain-
ent bias. A population prevalence of 0.02% for HLHS and
% for HLHS and associated CVM was used (conservative
stimate) (4,24,25). In light of recent evidence reporting an
ncreased prevalence of CVM, and the increased incidence
f CVM in utero (24,26–29), heritability estimates also
ere made using an HLHS prevalence of 0.08% and an
LHS and associated CVM prevalence of 5% (liberal
stimate). Heritability was estimated as a continuous trait
sing a semiquantitative method (HLHS  2, BAV or
ther CVM  1, and normal  0) based on the
ssumption that HLHS is inherited as an autosomal
ecessive trait (30). The mean in this model was con-
trained to equal the population prevalence. Therefore,
e estimated heritability: 1) using HLHS as either a
iscrete or a continuous trait, and 2) using a BAV and
ther CVM prevalence of either 2% or 5%. Values of p 
.05 were considered significant for additive genetic
ffects. The 95% confidence interval (CI) was determined
mpirically for heritability estimates using previously
escribed methods (31).
tatistical analysis: recurrence risk ratio. Using a family-
ased approach, we calculated recurrence risk ratios for
LHS and associated CVM for first-degree relatives and
iblings in the context of both unaffected parents and 1
arent with CVM. Recurrence risk ratio (R) was defined as
R  frequency (relatives)/frequency (population), where
he frequency in relatives is the number of first-degree
elatives of a proband over the total number of first-degree
elatives, and the frequency in the population is the preva-
ence in the general population (0.02% and 2% for HLHS
nd CVM, respectively) (32).
esults
tudy population. From October 2004 through October
006, 44 potential recruits were identified; 38 (86%)
LHS probands and their families were recruited (Fig.
Abbreviations
and Acronyms
BAV  bicuspid aortic
valve
CI  confidence interval
CVM  cardiovascular
malformation
HLHS  hypoplastic left
heart syndrome
SOLAR  Sequential
Oligogenic Linkage Analysis
Routines). Four families declined to participate, 1 proband was
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HLHS Is Heritable October 16, 2007:1590–5xcluded for medical reasons, and 1 family repeatedly
issed appointments. Among the 38 probands, 36 were
aucasian and 2 were African American; there were 28
ale and 10 female subjects (2.8:1), consistent with
tudies that have shown differences in rates of CVM by
ace or gender (28,29). A total of 235 family members
anging in age from 3 days to 74 years (130 male and 105
emale subjects with a gender ratio of 1.24:1 male:female)
ere evaluated, including 126 first-degree relatives. A
otal of 193 blood relatives of the probands were evalu-
ted (Table 1); 4 participants were not genetically related
o the probands.
Figure 1 Pedigrees Depicting the 38 HLHS Kindreds
Cardiovascular phenotype is represented by a box in the left upper quadrant for h
aortic valve (including bicuspid aortic valve), and in the right lower quadrant for ot
vascular phenotype, and a U denotes an individual not evaluated (unknown). Circl
elatives of 38 HLHS Probands Affected With CVM
Table 1 Relatives of 38 HLHS Probands Affected With CVM
Relationship Normal Affected Total
Fourth-degree plus 12 5 17
Third-degree 8 12 20
Grandparent 15 4 19
Avuncular 9 2 11
Half sibling 5 1 6
Parent 63 12 75
Sibling 35 10 45
Total 147 46 193*Excludes participants not genetically related to the proband.
CVM  cardiovascular malformation; HLHS  hypoplastic left heart syndrome. Hhenotype of probands. Aortic and mitral valve anatomy
aried among the 38 HLHS probands. Three combinations
ere observed: aortic atresia and mitral atresia (11), aortic
tresia and mitral stenosis (11), and aortic stenosis and
itral stenosis (16). No cases of aortic stenosis and mitral
tresia were observed. All aortic valves were both hypoplas-
ic and dysplastic (Table 2). Aortic atresia was present in 22
robands. Among 16 HLHS probands with aortic stenosis,
ssessment of aortic valve morphology identified BAV in 6
f 16 (38%) and unicuspid aortic valve in 10 of 16 (62%)
Figs. 2A and 2B). Of those with BAV, aortic valve
orphology was anterior-posterior in 5 and right-left in 1,
onsistent with relative morphology frequencies in isolated
AV (33). Of those with unicuspid aortic valves, aortic
alve morphology was unicommissural in 4 and acommis-
ural in 6. In addition, HLHS probands had dysplasia of the
stic left heart syndrome (HLHS), in the right upper quadrant for an abnormal
rdiovascular malformation (CVM). An empty symbol represents a normal cardio-
emale patients; squares  male patients. Probands indicated by arrows.
alve Phenotype in 38 HLHS Probands
Table 2 Valve Phenotype in 38 HLHS Probands
Valve Hypoplasia (%) Dysplasia (%)
Aortic 100 100
Mitral 100 94
Pulmonary 0 11
Tricuspid 0 56ypopla
her ca
es  fLHS  hypoplastic left heart syndrome.
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October 16, 2007:1590–5 HLHS Is Heritableitral (94%), tricuspid (56%), and pulmonary (11%) valves
Figs. 2C and 2D, Table 2).
henotype of family members. In addition to probands,
93 family members were evaluated; 46 (24%) had CVM
Table 1). In 21 families (55%), there were 2 or more
ffected individuals. Cardiovascular malformation was doc-
mented in 11 of 51 (22%) siblings and 23 of 126 (18%)
rst-degree relatives, including BAV (12, 10%), HLHS (4),
ortic root dilation (2), and 1 each with BAV and aortic root
ilation, aortic coarctation, atrioventricular septal defect,
entricular septal defect, and left superior vena cava. In
ddition, CVM was documented in 23 second-degree or
igher order relatives, including aortic valve malformation
ogether with BAV (14), aortic root dilation (3), aortic
oarctation (3), atrial septal defect (3), ventricular septal
efect (2), fatal unspecified cyanotic CVM as a newborn
nfant (2), and 1 each with HLHS, mitral valve abnormality,
nd truncus arteriosus. Among the 38 kindreds, first-degree
1) and second-degree (5) relatives required aortic valve
eplacement. Some individuals had multiple CVMs. Inter-
stingly, screening echocardiography resulted in the identi-
cation of previously unknown cases of BAV (10) and aortic
oot dilation (2). These findings underscore the importance
f screening first-degree relatives of HLHS patients to
dentify those at risk for latent disease, infective endocardi-
is, and aortic dissection.
eritability. The sequential sampling strategy resulted in
Figure 2 Valve Phenotype in HLHS Probands
All aortic valves were both dysplastic and hypoplastic. Aortic valve morphology
(A, B) showing the effective orifice of an anterior posterior bicuspid aortic valve
(arrows, A) and unicommissural unicuspid aortic valve (arrows, B) in the
parasternal short axis. Right-sided valve involvement (C, D) showing dysplasia
of the tricuspid (arrows, C) and pulmonary (arrow, D) valves in the apical
4-chamber and parasternal long axis, respectively. Abbreviations as in Figure 1.nformation from 652 relative pairs distributed nearly
C
rqually between first-degree and higher-order relatives
Table 1). The prevalence was initially constrained to
.02%; however, because the initial estimate was bound at
.0, the prevalence was liberated to 0.08% to achieve an
nbound estimate. The heritability of HLHS was esti-
ated as 0.99  0.002 (95% CI 0.59 to 1.0, p 
.00001). When the prevalence of HLHS and associated
VM was constrained to 2% and 5%, the heritability was
stimated as 0.96  0.08 (95% CI 0.76 to 1.0, p 
.00001) and 0.74  0.004 (95% CI 0.5 to 0.96, p 
.00001), consistent with previous findings in an inde-
endent population (11). Heritability estimates using
ale-female gender ratios of 1:1 (general population) or
.8:1 (study population) were not significantly different
data not shown). Using a semiquantitative method, the
eritability for HLHS and associated CVM was 0.32 
.10 (95% CI 0.13 to 0.53, p  0.0008) (2% prevalence)
nd 0.28  0.10 (95% CI 0.09 to 0.49, p  0.0008) (5%
revalence) confirming significant heritability. The re-
uction in heritability estimates using the semiquantita-
ive method questions the assumption that HLHS is
nherited as a simple Mendelian autosomal recessive
ondition, and implicates HLHS as a complex trait.
ecurrence risk. The frequency of first-degree relatives
ith HLHS or CVM was 3.5% and 18.3%, consistent with
revious findings (8). Siblings of HLHS probands were
iagnosed with HLHS in 8% (4 of 51) of cases and any
VM in 22% (11 of 51) of cases. Based on population
requencies, recurrence risk ratios for both first-degree
elatives and siblings were significantly increased. If 1 parent
as affected with CVM, the frequency and recurrence risk
atios of siblings with either HLHS or CVM increased
ubstantially (Table 3).
iscussion
he present study provides the first estimate of the herita-
ility of HLHS using variance decomposition methodology;
he finding of high heritability suggests that HLHS is
etermined largely by genetic factors. The heritability of
LHS and associated CVM is similar to the heritability of
eft-sided lesions reported by McBride et al. (12); however,
LHS composed only 23% of their study population.
ecause HLHS is a rare disease and kindreds identified by
HLHS proband are enriched for CVM, we also estimated
ypoplastic Left Heart Syndrome and CVM R
Table 3 Hypoplastic Left Heart Syndrome and CVM R
HLHS CVM
Frequency in first-degree relatives 3.5% 18.3%
Frequency in siblings 8% 22%
Frequency in siblings with 1 affected parent 21% 26%
First-degree relative R 175 9
Sibling R 515 11
Sibling R with 1 affected parent 1,050 13VM  cardiovascular malformation; HLHS  hypoplastic left heart syndrome; R  recurrence
isk ratio.
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HLHS Is Heritable October 16, 2007:1590–5eritability as a continuous trait. This analysis also showed
hat HLHS is heritable and implicates HLHS as a complex
rait.
Concepts of cardiac development have greatly influenced
ur understanding of the formation of the mesoderm-
erived, 4-chambered vertebrate heart. Human genetic
tudies have identified mutations in genes important for
arly heart formation that cause congenital CVM, support-
ng the idea that these birth defects are caused by alterations
uring cardiogenesis (34–38). There has been considerable
nterest in human conditions such as HLHS, in which
ndividual chambers or valves of the developing heart are
electively impaired (34). A widely accepted hypothesis is
hat HLHS develops as a result of embryonic alterations in
lood flow, such as premature narrowing of the foramen
vale (13) and aortic stenosis (39). This hypothesis is
upported by studies in the embryonic chick, in which
igation of the left atrium results in diminished flow through
he left ventricle, resulting in left ventricular hypoplasia
40). In addition, an alternative hypothesis for the etiology
f HLHS is being viewed as the summation of separate
enetic modules. Recent studies have investigated chamber-
pecific regulatory mechanisms (e.g., TBX5 and IRX1)
eading to formation of morphologically, functionally, and
olecularly distinct cardiac chambers (35,37). In this con-
ext, it has been suggested that left ventricular hypoplasia
ay result from a primary defect in myocardial growth
uring development. Unfortunately, there are presently no
xperimental models of HLHS to elucidate the relative
ontribution of these 2 hypotheses.
The definition of HLHS we used was not based on left
entricular hypoplasia alone (15); this is important because
eft ventricular hypoplasia is a feature of several different
VMs (e.g., unbalanced atrioventricular septal defect) be-
ieved to have diverse developmental origins. In the current
tudy, we used echocardiography to characterize the pheno-
ype of HLHS probands and family members. This detailed
henotyping identified the frequent occurrence of left-sided
nd right-sided valve dysplasia in HLHS probands and the
ncreased prevalence of BAV in probands and family mem-
ers. The latter observation and the identification of discor-
ant phenotypes (HLHS and BAV) in one set of identical
wins provides further support for the idea that HLHS is
llelic to BAV. Based on these findings, it can be speculated
hat the left ventricular hypoplasia present in HLHS is
econdary to a morphogenetic valve defect rather than a
rimary myocardial problem.
Previous studies have shown that the recurrence risk of
LHS is increased compared with other forms of CVM;
owever, these approximations may be underestimated
ecause they are based on epidemiologic and fetal studies
hat did not perform echocardiographic screening for
ubclinical BAV or other CVM (26,41,42). The recur-
ence risk ratios calculated in this study are significantly
igher than previously reported, particularly in the con-
ext of an affected parent. There is a potential samplingias for families with multiple affected children; however,
n this study, ascertainment was not based on family
istory. These findings may represent more accurate
stimations than previously reported in part because they
nclude definitive phenotyping on all first-degree rela-
ives. These new estimates support the idea that HLHS
s primarily caused by genetic factors and should be
onsidered when counseling families.
In summary, we have shown that HLHS has high
eritability, suggesting that it is almost entirely caused by
enetic effects. Therefore, using family-based linkage
nalysis, it should be possible to identify loci harboring
LHS-causing genes, especially in light of the propor-
ion of multiplex kindreds. The findings of left- and
ight-sided valve dysplasia in HLHS probands and asso-
iated BAV in family members suggest that HLHS is a
evere form of valve malformation. Therefore, we antic-
pate that HLHS-causing genes will be involved in valve
evelopment (e.g., transcription factors, signaling mole-
ules, or extracellular matrix proteins) (36,38). Elucida-
ion of the genetic basis of HLHS has significant
otential clinical implications; for example, genotype
tratification of HLHS probands may provide indications
or fetal intervention or specific postoperative pharmaco-
ogic strategies, as well as long-term prognostic informa-
ion such as the risk for right ventricular failure or
eurocognitive deficit.
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